Global Aptamers Market, By Type (Nucleic Acid Aptamers, Peptide Aptamers), Application (Diagnostics, Therapeutics, Research and Development), End User (Biotechnology and Pharmaceutical Companies, Contract Research Organization, Academic and Research Institutions), and Geography - Insights, Size, Share, Opportunity Analysis, & Industry Forecast till 2025
- Report code : CMI6774 |
- Industry :
Pharmaceutical
- Published On : Sep 2017 |
- Pages : 160 Pages |
- Format :
Aptamers Market: New Innovative Solution for Diverse Medical Applications
Aptamers are short single-stranded DNA or RNA (ssDNA or ssRNA) molecules that bind to a specific target protein, lipid, or nucleic acid molecules with high specificity. Aptamers can also be conjugated to drugs, working as drug-delivery systems. For example, aptamers have been conjugated with chemotherapy drugs to turn target and bind to only cancerous cells and leave healthy tissue untouched. Further, factors such as lesser chance of provoking undesired immune responses, high thermal stability, and cost-efficiency provide additional advantages to boost the demand for aptamers. These are produced through a technique called Systematic Evolution of Ligands by Exponential enrichment (SELEX), which is time-consuming and involves iterative steps. Thus, to overcome this disadvantage, Vivonics Inc. developed and patented a one-step rapid technique named Rapid Isolation of DNA Aptamers (RIDA) for the isolation of high affinity and high selectivity aptamers. These advancements are further expected to fuel adoption of aptamers.
Aptamers have attracted much attention recently for potential therapeutic and diagnostic purposes and have gained worldwide preference over antibodies owing to the former’s key benefits – lower cost, ability to not destroy neighboring cells, greater binding affinity, longer shelf life and, high specificity. These wide range of applications of aptamers have commanded medical industry to convey monetary clinical evidence and allow companies to significantly increase their influence to capture the untapped potential of aptamers, functioning as a key development opportunity that will propel the market growth.
The global aptamers market was valued at US$ 2,691.8 million in 2017 and is expected to witness a CAGR of 18.4% during the forecast period (2017 – 2025).
Figure 1. Global Aptamers Market Share, By Product Type (%)
Source: Coherent Market Insights Analysis (2017)
Increasing number of applications will drive the overall aptamers market
Aptamer products can be used as biosensors, diagnostics, research agents or can be considered as a tool for biomarker or drug discovery. It can also be used for targeted therapeutics and bio-industrial applications. Use of in-vivo aptamer have a vast advantages by avoiding the majority of the bench testing, saving several years and approximately 35% of the R&D cost. It permits the natural selection of drug candidates in whole animal models, which reduces the false starts and required fewer animals needed for drug evaluation. All these factors have attracted a large number of companies to invest in this market. Moreover, growing incidence of life-threatening diseases such cancer has directed many companies to introduce new detection assays based on aptamer therapy which will help to booster the growth of the aptamer market. In March 2017, Aptamer Sciences, Inc. unveiled multiprotein biomarker assay by using this technology for the detection of lung cancer. However, stringent regulations related the use of aptamer and low awareness about these molecules in emerging economies such as Asia-Pacific and Middle East and Africa are some of the factors that may pose a challenge to the growth of the market.
Continuous innovations and collaborations among manufacturers and research institutes is a prominent factor to fuel the aptamers market
Continuous investments by biotechnological and pharmaceutical companies and introduction of next generation products are the major factors that boost the growth of the aptamer market. Growing number of academic research laboratories investigating the potential of aptamers and rising number of products under clinical investigation also increased the rate of market penetration and demand for aptamers across the globe. For Instance, Ophthotech Corporation’s Fovista, a chemically synthesized nucleic acid aptamer, is currently under clinical investigation.
North America hold the maximum share of aptamers market in 2016, owing to presence of major key players and strategic collaborations among them, followed by Europe. Asia Pacific is also expected to grow at a substantial rate due to increased investments in R&D and setting up of in-house manufacturing and R&D facilities.
Key vendors in the aptamers market are collaborating with each other or independent research organizations and institutes to retain or increase their market share. For example, in March 2014, Siva Therapeutics initiated a research collaboration with SomaLogic, Inc. to determine the ability of SomaLogic’s SOMAmer (Slow-off Rate Modified Aptamer) reagents to actively target gold nanorods to solid tumors. This is expected to create more opportunity for aptamer for a more diverse range of applications in the near future.
Aptamers is revolutionizing the healthcare industry by providing the affinity towards a desired target with high selectivity and specificity. This enable research scientists to gain interest towards the field of aptamers technology with increasing support from public-private organizations. Companies such as Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, and SomaLogic, Inc. are collaborating with each other or independent research organizations and institutes to speed-up the research activities for the treatment of a number of diseases in order to decrease the time to market (TTM).
Market Dynamics
Aptamers offer significant advantages related to protein therapeutics in terms of synthetic accessibility, size, and modification by medicinal chemistry which in turn aid in developing highly effective therapy. Continuous investment and development of novel aptamers by market players is propelling the market growth over the forecast period. Ophthotech is developing novel therapeutics Fovista and Zimura (an aptamer), used to treat eye diseases. Furthermore, advancements in Systemic Evolution of Ligands by Exponential Enrichment (SELEX) process to extract high-quality aptamers for a more diverse range of applications and government support in developed regions are anticipated to fuel utilization of these products, leading to market growth.
Market Taxonomy
This report segments the global aptamers market on the basis of type, application, and end user. On the basis of type, the global aptamers market is classified into nucleic acid aptamers and peptide aptamers. Applications of aptamers include diagnostics, therapeutics, and research and development (R&D). Aptamers type is used for medical applications across pharmaceuticals and biotechnology companies, contract research organizations and academic and research institutions.
Key features of the study:
- This report provides in-depth analysis of aptamers and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year.
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launch or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global aptamers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, SomaLogic, Inc., NeoNeuro SAS, Aptagen, LLC, Aptus Biotech S.L., AM Biotechnologies, LLC, Base Pair Biotechnologies, and Vivonics Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type up-gradation, market expansion, and marketing tactics
- The global aptamers market report caters to various stakeholders in this industry including investors, researchers, aptamers manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the aptamers market.
Detailed Segmentation:
- Global Aptamers Market, By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- Global Aptamers Market, By Application:
- Diagnostics
- Therapeutics
- Research and Development
- Global Aptamers Market, By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Global Aptamers Market, By Geography:
- North America
- U.S.
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Canada
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Europe
- U.K.
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Germany
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Italy
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- France
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Russia
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Rest of Europe
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Asia Pacific
- China
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- India
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Japan
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- ASEAN
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Australia
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- South Korea
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Rest of Asia Pacific
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Latin America
- Brazil
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Mexico
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Rest of Latin America
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Middle East
- GCC
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Israel
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Africa
- North Africa
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Central Africa
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- South Africa
- By Type:
- Nucleic Acid Aptamers
- DNA-Based Aptamers
- RNA-Based Aptamers
- XNA-Based Aptamers
- Peptide Aptamers
- By Application:
- Diagnostics
- Therapeutics
- Research and Development
- By End User:
- Biotechnology and Pharmaceutical Companies
- Contract Research Organization
- Academic and Research Institutions
- Company Profiles
- Ophthotech Corporation*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Future Plans
- Aptamer Sciences, Inc.
- Novartis AG
- SomaLogic, Inc.
- NeoNeuro SAS
- Aptagen, LLC
- Aptus Biotech S.L.
- AM Biotechnologies, LLC
- Base Pair Biotechnologies
- Vivonics Inc.
- Aptamer Group
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
- Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet By Type
- Market Snippet By Application
- Market Snippet By End-User
- Market Snippet By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Supply Side Drivers
- Demand Side Drivers
- Economic Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Industry Trend
- Epidemiology/Prevalence/Incidence
- Cost Tier Down Analysis
- Global Aptamers Market, By Type, 2017 - 2025 (USD Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, 2017 - 2025
- Segment Trends
- Nucleic Acid Aptamers
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (USD Million)
- DNA-Based Aptamers
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (USD Million)
- RNA-Based Aptamers
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (USD Million)
- XNA-Based Aptamers
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (USD Million)
- Peptide Aptamers
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (USD Million)
- Global Aptamers Market, By Application, 2017 - 2025 (USD Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, 2017 - 2025
- Segment Trends
- Diagnostics
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, 2017 - 2025
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (USD Million)
- Research and Development
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (USD Million)
- Global Aptamers Market, By End-User, 2017 - 2025 (USD Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, 2017 - 2025
- Segment Trends
- Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (USD Million)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (USD Million)
- Contract Research Organization
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (USD Million)
- Global Aptamers Market, By Regions, 2017 - 2025 (USD Million)
- Introduction
- Market Share Analysis, By Region, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, For Regions, 2017 - 2025
- North America
- Market Share Analysis, By Country, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, By Country, 2017 - 2025
- U.S.
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Canada
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Europe
- Market Share Analysis, By Country, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, By Country, 2017 - 2025
- U.K.
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Germany
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Italy
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- France
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Russia
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Others
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Asia Pacific
- Market Share Analysis, By Country, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, By Country, 2017 - 2025
- China
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- India
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Japan
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- ASEAN
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Australia
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- South Korea
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Others
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Latin America
- Market Share Analysis, By Country, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, By Country, 2017 - 2025
- Brazil
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Mexico
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Others
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Africa
- Market Share Analysis, By Country, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, By Country, 2017 - 2025
- Northern Africa
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Central Africa
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- South Africa
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Middle East
- Market Share Analysis, By Country, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, By Country, 2017 - 2025
- GCC Countries
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Israel
- Country Trends
- Market Size and Forecast, By Type, 2017 - 2025 (USD Million)
- Market Size and Forecast, By Application, 2017 - 2025 (USD Million)
- Market Size and Forecast, By End-User, 2017 - 2025 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profiles
- Ophthotech Corporation
- Company Overview
- Type Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Aptamer Sciences, Inc.
- Company Overview
- Type Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Novartis AG
- Company Overview
- Type Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- SomaLogic, Inc.
- Company Overview
- Type Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- NeoNeuro SAS
- Company Overview
- Type Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Aptagen, LLC
- Company Overview
- Type Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Aptus Biotech S.L.
- Company Overview
- Type Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- AM Biotechnologies, LLC
- Company Overview
- Type Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Base Pair Biotechnologies
- Company Overview
- Type Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Vivonics Inc.
- Company Overview
- Type Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 90 market data tables and 40 figures on "Aptamers Market - Global forecast to 2025”.
Related Insights :
Share
Choose License Type
"How Can I Help You" ?
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Key Benefits
Custom Research Solution
Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment
We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality
We strive to provide most accurate and reliable research findings in our research reports.